Safety in infants of SPf66, a synthetic malaria vaccine, delivered alongside the EPI.
Open Access
- 1 May 1999
- journal article
- clinical trial
- Published by Wiley in Tropical Medicine & International Health
- Vol. 4 (5) , 377-382
- https://doi.org/10.1046/j.1365-3156.1999.00424.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in TanzaniaTropical Medicine & International Health, 1999
- Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of ColombiaVaccine, 1996
- A pilot safety and immunogenicity study of the malaria vaccine SPf66 in Gambian infantsParasite Immunology, 1995
- Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern TanzaniaThe Lancet, 1994
- Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in ColombiaThe Lancet, 1993
- Joel David Meyers, M.D., TributeThe Journal of Infectious Diseases, 1992
- The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivityVaccine, 1992
- Study of the safety and immunogenicity of the synthetic malaria SPf66 vaccine in children aged 1–14 yearsVaccine, 1992
- Vaccination in Infancy with Oral Poliomyelitis Vaccine and Diphtheria, Tetanus, Pertussis VaccineBMJ, 1963
- SABIN VACCINE AND COMBINED DIPHTHERIA-TETANUS-PERTUSSIS IMMUNISATIONThe Lancet, 1961